FAH President and CEO Chip Kahn released the following statement regarding President Trump’s Executive Order (EO) titled “Lowering Drug Prices By Once Again Putting Americans First“:

“President Trump’s EO to lower drug costs for Americans takes an important step forward, ensuring that the 340B program is fulfilling its intended purpose – putting patients first and bringing long-needed accountability that will lower Medicare’s drug costs.

“The EO embraces the first term policy to adjust Medicare outpatient hospital drug payments for the deep 340B discounts. This EO remedies process issues that sidetracked the initiative previously. So, beneficiaries will see lower drug cost sharing while fairness of drug payment will increase.”

###